Evidence map›Paper›PMID 42125143›Full record

ArticleChemical science2026

Yanbo Zhang, Yichao Xie, Baicheng Guo, Yingchao Dou, Dandan Yang, Jun-Long Niu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanbo ZhangCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.
Yichao XieCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.
Baicheng GuoCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.
Yingchao DouCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.ORCID https://orcid.org/0000-0001-5533-0902
Dandan YangCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.ORCID https://orcid.org/0000-0002-1880-8417
Jun-Long NiuCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University Zhengzhou 450001 China yingchaodou@zzu.edu.cn yangdandan@zzu.edu.cn niujunlong@zzu.edu.cn.ORCID https://orcid.org/0000-0001-8012-4676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The catalytic asymmetric synthesis of axially chiral compounds has attracted growing attention over the past decades. C-O axially chiral compounds represent a distinctive class of atropisomers characterized by a unique dual-axial architecture. Their atroposelective construction remains a formidable challenge due to inherent low rotational barriers and high conformational flexibility. Current catalytic approaches rely predominantly on enantioselective desymmetrization of preformed diaryl ethers. Here, we report an unprecedented

Identifiers

PMID42125143
PMCPMC13160367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.